NEPAL4: Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Recruiting
CT.gov ID
NCT05504928
Collaborator
(none)
2,300
1
1
54
42.6

Study Details

Study Description

Brief Summary

The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.

Condition or Disease Intervention/Treatment Phase
  • Other: School nurse program
N/A

Detailed Description

Three in four children worldwide grow up in regions of the world where patterns of acute rheumatic fever and rheumatic heart disease are endemic and where rheumatic heart disease accounts for >300'000 deaths every year. Evidence from a systematic review and meta-analysis of 10 studies indicated an incidence of group A β-hemolytic streptococcal (GAHBS) pharyngitis among children in low- to upper-middle income countries of 10.8 per 100 child-years with considerable heterogeneity between individual reports.

Timely detection of GAHBS pharyngitis by use of rapid antigen detection tests and initiation of antibiotic treatment represents an effective target for primary prevention. Early stages of rheumatic heart disease manifest with morphologic or functional valvular changes that can only be detected with echocardiography and are therefore latent. Latent stages of rheumatic heart disease are reversible with timely initiation of secondary antibiotic prophylaxis. A school-centered approach provides an opportunity to provide equitable access to a primary and secondary prophylaxis program with the potential to substantially reduce the burden of rheumatic heart disease in endemic regions.

All children 5-16 years of age from Tulsi Secondary Boarding School in Tulsipur, Nepal, will be eligible for inclusion. Sociodemographic characteristics and will be collected by means of a standardized interview. In a study using an interrupted time series design, prevalence of latent rheumatic heart disease will be measured by means of transthoracic echocardiography before, and two and four years after implementation of a dedicated school nurse program providing health care through assessment, intervention and follow-up of GAHBS pharyngitis and facilitation of secondary antibiotic prophylaxis for children with latent rheumatic heart disease.

Investigators expect to find a decrease in prevalence of rheumatic heart disease after implementation of a dedicated school-centered prevention program primarily led by school nurses, and to identify sociodemographic and environmental factors associated with the development and progression of rheumatic heart disease.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2300 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Interrupted time series designInterrupted time series design
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of a School-centered Primary and Secondary Prevention Program on Prevalence of Latent Rheumatic Heart Disease
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental: Implementation of a dedicated school nurse program

School nurse program providing health care through assessment, intervention and follow-up of group A β-hemolytic streptococcal pharyngitis and facilitation of secondary antibiotic prophylaxis for children with latent rheumatic heart disease.

Other: School nurse program
School nurse program providing health care through assessment, intervention and follow-up of group A β-hemolytic streptococcal pharyngitis and facilitation of secondary antibiotic prophylaxis for children with latent rheumatic heart disease.

Outcome Measures

Primary Outcome Measures

  1. Prevalence of definite or borderline Rheumatic Heart Disease [4 years]

    Prevalence of definite or borderline Rheumatic Heart Disease according to the criteria of the World Heart Federation as assessed by systematic echocardiographic screening

Secondary Outcome Measures

  1. Group A β-hemolytic streptococcal pharyngitis [4 years]

    Number of patients with group A β-hemolytic streptococcal pharyngitis within study participation

  2. Acute rheumatic fever [4 years]

    Number of patients with acute rheumatic fever within study participation

  3. Rheumatic heart disease [4 years]

    Number of patients with rheumatic heart disease within study participation

  4. Adverse reactions to penicillin injections [4 years]

    Number of patients with adverse reactions to penicillin injections within study participation

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 5-16 years

  • Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.

Exclusion Criteria:
  • Children / primary caregivers not providing informed consent to participate

  • Children not attending Tulsi Secondary Boarding School in Tulsipur.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tulsi Secondary Boarding School Tulsipur Nepal 22412

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Principal Investigator: Thomas Pilgrim, Prof. Dr., Bern University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT05504928
Other Study ID Numbers:
  • NEPAL4
First Posted:
Aug 17, 2022
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital Inselspital, Berne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2022